Elektromyostimulation (EMS) bei kardiologischen Patienten

Fritzsche, Dirk; Fruend, Andreas; Schenk, Soren; Mellwig, Klaus-Peter; Kleinöder, Heinz; Gummert, Jan; Horstkotte, Dieter

doi:10.1007/s00059-010-3268-8

Cited by 24 publications

(68 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Not perfectly addressed within the present research design, but based on the rather consistent effects of WB-EMS [ 16 , 20 – 27 , 44 ] on body composition provided by the literature, we think it is legitimate to discuss the effect of an additional WPS on recognized WB-EMS protocols with respect to body fat and cardiometabolic indices in older adults. The only study that focuses on people with SO, however, did not observe significant corresponding differences between WB-EMS with and without protein supplementation ([ 22 , 44 ].…”

Section: Discussionmentioning

confidence: 91%

“…Although WB-EMS has been frequently described (e.g. [ 20 , 22 , 23 , 25 , 26 , 31 – 34 ]), a brief introduction of this predominately resistance type exercise will be given. WB-EMS is based on the recognized local electromyostimulation predominately applied in the treatment of muscular injuries.…”

Section: Methodsmentioning

confidence: 99%

“…However, it is unrealistic to assume that people with SO will achieve the intensity and frequency of exercise recommended for positively impacting disabling conditions or obesity [ 19 ]. In this context, whole-body electromyostimulation (WB-EMS), an effective, time-efficient, joint-friendly and highly customized further development of the recognized local EMS application predominately applied in therapy [ 16 , 20 – 27 ], may be a good choice for older subjects at risk for sarcopenic obesity (SO).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Effect of whole-body electromyostimulation and / or protein supplementation on obesity and cardiometabolic risk in older men with sarcopenic obesity: the randomized controlled FranSO trial

Kemmler¹,

Kohl

Freiberger³

et al. 2018

BMC Geriatr

View full text Add to dashboard Cite

BackgroundSarcopenic Obesity (SO) is characterized by low lean and high fat mass; i.e. from a functional aspect a disproportion between engine (muscle) and mass to be moved (fat). At present, most research focuses on the engine, but the close “cross talk” between age-associated adipose and skeletal muscle tissue inflammation calls for comprehensive interventions that affect both components alike. Protein and exercise are likely candidates, however with respect to the latter, the enthusiasm for intense and frequent exercise is rather low, especially in functionally limited older people. The aim of this study was therefore to evaluate the effect of whole-body electromyostimulation (WB-EMS), a time-efficient, joint-friendly and highly customizable exercise technology, on obesity parameters and cardiometabolic risk in men with SO.MethodsOne-hundred community-dwelling (cdw) Bavarian men ≥70 years with SO were randomly assigned to either (a) whey protein supplementation (WPS), (b) WB-EMS and protein supplementation (WB-EMS&P) or (c) non-intervention control (CG). Protein supplementation contributed to an intake of 1.7–1.8 g/kg/body mass/d, WB-EMS consisted of 1.5 × 20 min/week (85 Hz, 350 μs, 4 s of strain–4 s of rest) with moderate-high intensity. Using an intention to treat approach with multiple imputation, the primary study endpoint was total body fat mass (TBF), secondary endpoints were trunk fat mass (TF), waist circumference (WC) and total-cholesterol/HDL-cholesterol ratio (TC/HDL-C).ResultsAfter 16 weeks of intervention, TBF was reduced significantly in the WPS (− 3.6 ± 7.2%; p = 0.005) and WB-EMS&P (− 6.7 ± 6.2%; p < 0.001), but not in the CG (+ 1.6 ± 7.1%; p = 0.191). Changes in the WB-EMS&P (p < 0.001) and the WPS group (p = 0.011) differ significantly from the CG. TF decreased in the WB-EMS&P (p < 0.001) and WPS (p = .117) and increased in the CG (p = .159); WC decreased significantly in the treatment groups and was maintained in the CG. Lastly, the TC/HDL-C ratio improved significantly in the WB-EMS&P and WPS group and was maintained in the CG. Significant differences between WB-EMS&P and WPS were determined for waist circumference only (p = 0.015; TBF: p = 0.073; TF: p = 0.087; TC/HDL-C: p = .773).ConclusionModerate-high dosed whey protein supplementation, especially when combined with WB-EMS, may be a feasible choice to address obesity and cardiometabolic risk in older cdw men with SO unable or unmotivated to exercise conventionally.Trial registration numberClinicalTrials.gov NCT02857660; registration date: 05/01/2017.

show abstract

Section: Discussionmentioning

confidence: 91%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Effect of whole-body electromyostimulation and / or protein supplementation on obesity and cardiometabolic risk in older men with sarcopenic obesity: the randomized controlled FranSO trial

Kemmler¹,

Kohl

Freiberger³

et al. 2018

BMC Geriatr

View full text Add to dashboard Cite

show abstract

“…Its application includes mild physical exercises and enables a simultaneous activation of almost all large muscles by electrodes integrated in a vest and belts. The efficacy of WB-EMS in increasing muscle strength and mass in athletes [ 18 ], was also demonstrated in elderly, sedentary persons and patients with chronic heart failure [ 19 – 24 ], but studies with cancer patients are still lacking. Regular exercise requires an adequate nutrient and energy supply to enable muscle growth and prevent muscle degradation.…”

Section: Introductionmentioning

confidence: 99%

Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial

et al. 2018

View full text Add to dashboard Cite

BackgroundPhysical exercise and nutritional treatment are promising measures to prevent muscle wasting that is frequently observed in advanced-stage cancer patients. However, conventional exercise is not always suitable for these patients due to physical weakness and therapeutic side effects. In this pilot study, we examined the effect of a combined approach of the novel training method whole-body electromyostimulation (WB-EMS) and individualized nutritional support on body composition with primary focus on skeletal muscle mass in advanced cancer patients under oncological treatment.MethodsIn a non-randomized controlled trial design patients (56.5% male; 59.9 ± 12.7 years) with advanced solid tumors (UICC III/IV, N = 131) undergoing anti-cancer therapy were allocated to a usual care control group (n = 35) receiving individualized nutritional support or to an intervention group (n = 96) that additionally performed a supervised physical exercise program in form of 20 min WB-EMS sessions (bipolar, 85 Hz) 2×/week for 12 weeks. The primary outcome of skeletal muscle mass and secondary outcomes of body composition, body weight and hand grip strength were measured at baseline, in weeks 4, 8 and 12 by bioelectrical impedance analysis and hand dynamometer. Effects of WB-EMS were estimated by linear mixed models. Secondary outcomes of physical function, hematological and blood chemistry parameters, quality of life and fatigue were assessed at baseline and week 12. Changes were analyzed by t-tests, Wilcoxon signed-rank or Mann-Whitney-U-tests.ResultsTwenty-four patients of the control and 58 of the WB-EMS group completed the 12-week trial. Patients of the WB-EMS group had a significantly higher skeletal muscle mass (0.53 kg [0.08, 0.98]; p = 0.022) and body weight (1.02 kg [0.05, 1.98]; p = 0.039) compared to controls at the end of intervention. WB-EMS also significantly improved physical function and performance status (p < 0.05). No significant differences of changes in quality of life, fatigue and blood parameters were detected between the study groups after 12 weeks.ConclusionsSupervised WB-EMS training is a safe strength training method and combined with nutritional support it shows promising effects against muscle wasting and on physical function in advanced-stage cancer patients undergoing treatment.Trial registrationClinicalTrials.gov NCT02293239 (Date: November 18, 2014).

show abstract

“…MCP belongs to a number of recently introduced new device‐based concepts in heart failure treatment (19): enhanced external counterpulsation (EECP) (20,21), low‐frequency electrical stimulation (22), electromyostimulation (EMS) (23), or cardiac contractility modulation (24). The use and effects of these devices are rather diverse.…”

Section: Discussionmentioning

confidence: 99%

Acute Effects of Muscular Counterpulsation Therapy on Cardiac Output and Safety in Patients With Chronic Heart Failure

et al. 2011

Self Cite

View full text Add to dashboard Cite

Our aim was to investigate acute effects of muscular counterpulsation (MCP) on hemodynamic parameters and to evaluate its safety in regard to myocardial integrity and interferences with implanted rhythm devices in patients with chronic heart failure (CHF). A total of 22 patients with CHF (16 male, 67.8 ± 9.5 years, New York Heart Association [NYHA] class II + III, left ventricular ejection fraction 29.6 ± 6.6%) were treated with MCP for 3 consecutive days for 45 min, while hemodynamic parameters were measured noninvasively by bioimpedance (Task Force Monitor). Laboratory control and a complete device testing were performed prior to the first and after the third treatment. In addition, continuous rhythm device interrogation was performed online during the first MCP application. During each application, a significant increase in cardiac output (CO; average change +2.08 ± 2.33 L/min, P < 0.05) was documented. This increase was due to a decrease of total peripheral resistance (-336 ± 530 dyn × s/cm(5) , P < 0.05), to an augmented stroke volume (+8.35 ± 20.86 mL, P = n.s.), and an increase in heart rate (+17.12 ± 21.12 bpm, P < 0.05). Cardiac markers and enzymes were within normal limits at all times and did not increase during treatment. MCP stimuli were monitored using surface electrocardiogram, and no abnormal sensing or pacing events occurred. MCP acutely improves CO in patients with stable CHF. No adverse influence on myocardial integrity was observed nor were any inappropriate sensing or pacing artifacts detected in patients with implanted rhythm devices.

show abstract

Elektromyostimulation (EMS) bei kardiologischen Patienten

Abstract: The results may indicate the enormous potential of EMS for the treatment of patients within the cardiologic arena, especially those with CHF.

Cited by 24 publications

References 20 publications

Effect of whole-body electromyostimulation and / or protein supplementation on obesity and cardiometabolic risk in older men with sarcopenic obesity: the randomized controlled FranSO trial

Effect of whole-body electromyostimulation and / or protein supplementation on obesity and cardiometabolic risk in older men with sarcopenic obesity: the randomized controlled FranSO trial

Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial

Acute Effects of Muscular Counterpulsation Therapy on Cardiac Output and Safety in Patients With Chronic Heart Failure

Contact Info

Product

Resources

About